When it comes to GI cancers, knowledge is power—and molecular testing is key to better treatment outcomes. Here’s why: ?? 26% of global cancer cases are GI-related, with 35% of cancer deaths ?? Targeted therapies based on molecular profiling improve survival rates ? Liquid biopsy with plasma NGS makes testing faster and more efficient ?? Understanding tumor biology helps avoid ineffective treatments Molecular testing should be the standard in all GI cancers. Talk to your doctor today! ?? #GIcancer #MolecularTesting #TargetedTherapy #CancerCare #Circulogene
关于我们
Headquartered in Birmingham, Ala., CIRCULOGENE is an innovative molecular diagnostics company founded and operated by a team of experienced industry executives and skilled molecular diagnostics scientists. Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence. One tube, one week, complete results. Somatic + Germline; Blood + Tissue + Buccal; DNA + RNA + MSI + PD-L1. CONTACT [email protected] For Asia Pacific inquiries, please email [email protected] For Middle Eastern inquiries, please email [email protected]
- 网站
-
https://www.circulogene.com
CIRCULOGENE的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Birmingham,Alabama
- 类型
- 私人持股
- 创立
- 2015
- 领域
- cfDNA、Liquid Biopsy、Tumor Monitoring、Laboratory Testing、Molecular Diagnostics、Genomics、Tissue Biopsy和Next-Generation Sequencing
地点
-
主要
3125 Independence Dr
US,Alabama,Birmingham,35209
CIRCULOGENE员工
-
Phil Morrison
Healthcare & Life Sciences Business Leader | Change Agent | Building High-Performing Teams | Driving Sales Growth & Innovation |
-
J. Kevin Day, PhD, HCLD (ABB)
Vice President, Laboratory Operations at Circulogene
-
Michael Mullen
CEO at CirculoGene
-
Christy Lee, MBA
Vice President Finance
动态
-
March is Kidney Cancer Awareness Month! Over 79,000 new cases of kidney cancer are diagnosed in the U.S. every year. Let’s raise awareness together. #KidneyCancerAwareness #GenomicInsights #CancerPrevention
-
-
Are lung cancer patients getting the therapies they need? Up to 70% of patients don't receive life-extending targeted therapies—not because they don’t qualify, but because key mutations go undetected due to incomplete or delayed testing. ?? That’s where Circulogene’s TumorClear makes a difference. With fast, comprehensive molecular profiling, we ensure no mutation is overlooked, helping patients access the right treatments sooner. Timely, accurate testing can lead to better outcomes and more treatment options. ?? Better testing today means better lung cancer care tomorrow. #PulmonaryCare #LungCancerTesting #PrecisionMedicine #Circulogene #PatientCare
-
Why Choose Circulogene? ?? At Circulogene, we’re redefining precision oncology with cutting-edge liquid biopsy technology. Here’s why clinicians and patients trust us: ? Fast results – Get complete results for DNA, RNA, MSI, TMB, and PD-L1 in just one week ? Comprehensive testing – For all stages of cancer ? Advanced detection – DNA + RNA sequencing for a fuller picture ? Liquid biopsy benefits – Less invasive, more efficient than traditional methods Because every moment matters in cancer care. ?? #PrecisionMedicine #LiquidBiopsy #Circulogene #CancerDetection #OncologyInnovation
-
March is Colorectal Cancer Awareness Month! Early detection is key. Circulogene's liquid biopsy tests are helping identify colorectal cancer in its earliest stages, offering hope for better outcomes. Together, we can make a difference. ????? #ColorectalCancer #EarlyDetection #CancerPrevention #GenomicInsights
-
-
Unlock the Power of Precision Treatment for Lung Cancer ?? Did you know molecular testing can double survival rates for advanced NSCLC? By identifying key mutations like EGFR, ALK, and KRAS, doctors can match you with the most effective targeted therapies. Liquid biopsy with plasma NGS can offer faster and potentially more comprehensive results than traditional tissue testing—benefiting both advanced and early-stage patients. ?? Take control of your care—ask your doctor about Circulogene molecular testing! #LungCancer #MolecularTesting #LiquidBiopsy #NSCLC #Circulogene
-
Did you know that stress can affect overall health, including cancer risk? ??♂? Take time for self-care this National Cancer Prevention Month and prioritize mental well-being—it’s an essential part of prevention. #SelfCare #CancerPreventionMonth
-
-
Think you’re too young to worry about cancer prevention? Think again! ??? Taking steps to reduce your risk is important at any age. This National Cancer Prevention Month, let’s bust myths and take action. #CancerPrevention #MythBusting
-
-
Cancer prevention starts at work too! ?? Encourage your workplace to support healthy habits, like nutritious snacks and walking breaks. Together, we can create environments that promote health and well-being. #WorkplaceWellness #CancerPrevention
-
-
This February, we shine a light on Gallbladder and Bile Duct Cancer Awareness Month. ?? These rare cancers often show no early signs, making awareness and education critical. Learn about symptoms and risk factors to protect yourself and your loved ones. Together, we can raise awareness. ??? #BileDuctCancer #GallbladderCancerAwareness
-